Yossi Maimon is a senior executive with over 20 years of experience in corporate finance including private financing, IPO, follow on offerings, strategic collaborations and M&A. Yossi previously served as Chief Financial Officer at Protalix BioTherapeutics (NYSE: PLX), where he led the company’s IPO process, multiple follow on offerings and various strategic licensing and collaboration agreements. Prior to Protalix, Yossi was the Chief Financial Officer of ColBar LifeScience where he led corporate finance activities, fundraising and legal aspects of the Company including the sale of Colbar to Johnson & Johnson (NYSE: JNJ). Yossi earned a B.A from the City University of New York and an MBA from Tel Aviv University. Yossi is licensed as a Certified Public Accountant in New York and Israel.